ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

The blind men 'see' the elephant-the many faces of fatty liver disease

Madhusudana Girija Sanal*
World Journal of Gastroenterology2008-2-14
5阅读
引用收藏
分享

摘要

Nonalcoholic fatty liver disease (NAFLD) is a group of diseases with excess fat in liver in the absence of a poorly defined limit of alcohol consumption. Most common variety, a universal public health problem, is associated with insulin resistance caused by a host of genetic and epigenetic defects modulated by life style and environmental factors. In fact the term NAFLD is loose to incorporate so many etiologies except alcoholism and few other etiologies, presenting as fat in liver. However as a sign fatty liver is very important in predicting the risk of diabetes, cardiovascular disease, stroke, cirrhosis and cancer. Abnormal fat accumulation can result from several defects in nuclear receptors associated with lipid sensing, synthesis and oxidation like LXR, FXR, SREBP, ChREBP and PPAR; defects in the lipid influx-efflux channels, insulin signaling, proteins involved in fatty acid catabolism, defects in adipose tissue development and function, inappropriate nutrition and finally defects in neural regulatory mechanisms. The progress of the disease is determined by the basic defects which results in fat accumulation, an individual’s immunological response to the accumulated fat and its derivatives and the oxidant stress response. Congregation of unrelated genetic defects under same diagnosis ‘NAFLD’ can result in inefficient patient management. Further studies are required to understand the molecular basis of fatty liver to enable a personalized management of diseases presenting as fatty liver in the absence of alcohol abuse.

学科与关键词

关键词
Nonalcoholic fatty liver diseaseInsulin resistanceLipid homeostasisPrimate evolutionLipid channelsLipoproteinAdipokinesNuclear receptorsBile acid metabolismPersonalized medicine
相关
加载中…
  • Genetics and Epigenetics in the Clinic: Precision Medicine in the Management of Fatty Liver Disease
    Cespiati, Annalisa; Youngson, Neil A.; Tourna, Aikaterini; Valenti, Luca*Current Pharmaceutical Design, 2020, 26(10): 998-1009.被引 12
  • Current insights in molecular characterization of non-alcoholic fatty liver disease and treatment
    Che, Wensheng; Zhao, Ming; Li, Xiaoqing; Li, Chunlong*; Cho, William C.*; Yu, Shan*Frontiers in Endocrinology, 2022, 13: 1002916.被引 2
  • 非酒精性脂肪肝疾病与脂质变化
    李宏; 张秀英; 徐尚; 刘万刚中国兽医杂志, 2013, (06): 59-61.
查看全部 →

发表信息

论文状态
公开发表
期刊
World Journal of Gastroenterology
发表日期
2008-02-14
卷期
第 06 期
页码
831-844
语言
ENGLISH
成果收录
CHINAJOURNAL

作者

  • M

    Madhusudana Girija Sanal (通讯) (第一作者)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417